90 related articles for article (PubMed ID: 33952479)
21. Donor
Zhang M; Tajima S; Shigematsu T; Fu R; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Egashira N; Masuda S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340188
[No Abstract] [Full Text] [Related]
22. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
[TBL] [Abstract][Full Text] [Related]
23. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T
Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187
[TBL] [Abstract][Full Text] [Related]
24. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
[TBL] [Abstract][Full Text] [Related]
25. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.
Willrich MA; Rodrigues AC; Cerda A; Genvigir FD; Arazi SS; Dorea EL; Bernik MM; Bertolami MC; Faludi A; Largura A; Baudhuin LM; Bryant SC; Hirata MH; Hirata RD
Clin Chim Acta; 2013 Jun; 421():157-63. PubMed ID: 23501331
[TBL] [Abstract][Full Text] [Related]
26. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
27. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
Oncotarget; 2017 May; 8(21):35244-35254. PubMed ID: 27806328
[TBL] [Abstract][Full Text] [Related]
28. CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele.
Bolbrinker J; Seeberg S; Schostak M; Kempkensteffen C; Baelde H; de Heer E; Kreutz R
Drug Metab Dispos; 2012 Apr; 40(4):639-41. PubMed ID: 22214815
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
[TBL] [Abstract][Full Text] [Related]
30. Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.
Rekers NV; Flaig TM; Mallat MJK; Spruyt-Gerritse MJ; Zandbergen M; Anholts JDH; Bajema IM; Clahsen-van Groningen MC; Yang J; de Fijter JW; Claas FHJ; Brakemeier S; Lachmann N; Kreutz R; de Heer E; Budde K; Bolbrinker J; Eikmans M
Transplantation; 2017 Sep; 101(9):2017-2025. PubMed ID: 27926596
[TBL] [Abstract][Full Text] [Related]
31. CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients.
Htun YY; Swe HK; Saw TM
Transplant Proc; 2018 May; 50(4):1034-1040. PubMed ID: 29731062
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
33. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Int J Clin Exp Pathol; 2014; 7(11):7597-609. PubMed ID: 25550796
[TBL] [Abstract][Full Text] [Related]
34. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
35. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours.
Onodera M; Endo K; Naito T; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Kakuta Y; Negoro K; Kinouchi Y; Shimosegawa T
Digestion; 2018; 97(1):90-96. PubMed ID: 29393157
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract][Full Text] [Related]
38. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
[TBL] [Abstract][Full Text] [Related]
39. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
